Recombinant Bovine Growth Hormone vs Titanium Dioxide: which is worse?

What is Recombinant Bovine Growth Hormone?

Recombinant bovine growth hormone (rBGH), also called recombinant bovine somatotropin (rBST), is a synthetically produced version of the naturally occurring cattle growth hormone, manufactured using genetically engineered E. coli bacteria. Injected into dairy cows, it increases milk production by 10-15%. It was FDA-approved in 1993 under the brand name Posilac (originally Monsanto, later Elanco).

What is Titanium Dioxide?

Titanium dioxide (TiO2) is a naturally occurring white mineral used as a food colorant, whitening agent, and opacity enhancer. In food applications, it exists as nano-sized and micro-sized particles. It is one of the most widely produced industrial minerals globally, used in paints, plastics, sunscreens, and food products.

Documented risks

Recombinant Bovine Growth Hormone: The central human health concern is that rBGH treatment significantly elevates insulin-like growth factor 1 (IGF-1) levels in treated cows' milk. IGF-1 is a naturally occurring growth hormone that promotes cell growth and division. Multiple epidemiological studies have associated elevated blood IGF-1 levels with increased cancer risk in humans. A 1998 study in The Lancet (Hankinson et al.) found that women with the highest IGF-1 blood levels had approximately 7 times the breast cancer risk compared to those with the lowest levels. A 2004 meta-analysis in JNCI (the Journal of the National Cancer Institute) confirmed significant associations between high IGF-1 levels and breast, prostate, and colorectal cancer risk. The mechanistic question is whether consuming rBGH-treated milk raises blood IGF-1 levels in humans. The FDA and WHO/FAO Codex Alimentarius concluded that IGF-1 in milk is a protein largely digested in the GI tract before absorption. Canadian regulatory researchers challenged this, arguing that pasteurization reduces proteases that would otherwise break down IGF-1, potentially allowing more intact IGF-1 to survive digestion. The Codex Alimentarius Commission made history in 1999 by declining to endorse rBST safety maximum residue limits — a split vote (33 in favor of the MRL, 29 against, with abstentions) demonstrating fundamental international disagreement. This is one of very few cases where Codex failed to establish a safety standard. Animal welfare is a second major concern: Health Canada's comprehensive 1999 review found that rBGH-treated cows had 25% higher rates of clinical mastitis, 50% higher lameness risk, increased reproductive problems, and shortened productive lifespans, requiring substantially more antibiotic treatment — an antibiotic resistance concern. Canada rejected rBGH approval in 1999 after its scientific review; the EU banned it in 1999.

Titanium Dioxide: The EU banned titanium dioxide as a food additive in 2022 following EFSA's landmark 2021 safety assessment (EFSA Journal 2021;19(5):6585), which concluded that titanium dioxide 'can no longer be considered safe as a food additive.' The primary concern is genotoxicity from nanoparticles: EFSA determined it was impossible to rule out the risk of DNA damage (genotoxicity) from TiO2 nanoparticles at typical food use exposure levels. In vitro studies have demonstrated that TiO2 nanoparticles cause DNA strand breaks in intestinal epithelial cells and induce oxidative stress. A 2019 study in Nature Communications found TiO2 nanoparticles could disrupt gut microbiome balance and intestinal barrier function in mice models. Multiple studies have suggested effects on gut permeability and immune function. IARC classifies titanium dioxide as Group 2B (possible human carcinogen) for inhalation exposure in occupational settings — primarily relevant to workers handling TiO2 dust, based on rat lung cancer studies. While inhalation and oral exposure are different routes, EFSA determined that the genotoxicity concerns from nanoparticles applied to oral food use as well. Following the EU ban, California attempted to pass legislation banning TiO2 in candy (along with other additives) in 2022. The bill was signed in modified form. Mars reformulated EU Skittles to remove TiO2. The US FDA has not announced specific action on food-grade TiO2 as of 2025, though USRTK and other organizations are calling for a US ban.